These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 27081214)
1. Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems. Youngren-Ortiz SR; Gandhi NS; España-Serrano L; Chougule MB Kona; 2016 Feb; 33():63-85. PubMed ID: 27081214 [TBL] [Abstract][Full Text] [Related]
2. Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems. Youngren-Ortiz SR; Gandhi NS; España-Serrano L; Chougule MB Kona; 2017; 34():44-69. PubMed ID: 28392618 [TBL] [Abstract][Full Text] [Related]
3. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations. Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971 [TBL] [Abstract][Full Text] [Related]
4. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, Acosta MF; Muralidharan P; Grijalva CL; Abrahamson MD; Hayes D; Fineman JR; Black SM; Mansour HM Ther Adv Respir Dis; 2021; 15():1753466621998245. PubMed ID: 33719747 [TBL] [Abstract][Full Text] [Related]
5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models. Acosta MF; Muralidharan P; Meenach SA; Hayes D; M-Black S; Mansour HM Curr Pharm Des; 2016; 22(17):2522-31. PubMed ID: 26831643 [TBL] [Abstract][Full Text] [Related]
7. Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Muralidharan P; Mallory E; Malapit M; Hayes D; Mansour HM Pharmaceutics; 2014 Jun; 6(2):333-53. PubMed ID: 24955820 [TBL] [Abstract][Full Text] [Related]
8. Same lung deposited dose in dog dosing a fine and coarse aerosol indicates no difference in intranasal filtration. Brülls M; Oag S; Karlsson CA; Lamm Bergström E Int J Pharm; 2022 Aug; 624():121977. PubMed ID: 35792234 [TBL] [Abstract][Full Text] [Related]
9. Effective nebulization of interferon-γ using a novel vibrating mesh. Sweeney L; McCloskey AP; Higgins G; Ramsey JM; Cryan SA; MacLoughlin R Respir Res; 2019 Apr; 20(1):66. PubMed ID: 30943978 [TBL] [Abstract][Full Text] [Related]
10. The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy. Silva AC; Costa MP; Zacaron TM; Ferreira KCB; Braz WR; Fabri RL; Frézard FJG; Pittella F; Tavares GD Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204314 [TBL] [Abstract][Full Text] [Related]
11. Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation. Lin HL; Fang TP; Cho HS; Wan GH; Hsieh MJ; Fink JB Pulm Pharmacol Ther; 2018 Feb; 48():225-231. PubMed ID: 29277689 [TBL] [Abstract][Full Text] [Related]
12. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH. Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627 [TBL] [Abstract][Full Text] [Related]
13. In-vitro/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation. Hassan A; Salah Eldin R; Abdelrahman MM; Abdelrahim ME Exp Lung Res; 2017 Feb; 43(1):19-28. PubMed ID: 28394653 [TBL] [Abstract][Full Text] [Related]
14. The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress. Dua K; Wadhwa R; Singhvi G; Rapalli V; Shukla SD; Shastri MD; Gupta G; Satija S; Mehta M; Khurana N; Awasthi R; Maurya PK; Thangavelu L; S R; Tambuwala MM; Collet T; Hansbro PM; Chellappan DK Drug Dev Res; 2019 Sep; 80(6):714-730. PubMed ID: 31691339 [TBL] [Abstract][Full Text] [Related]
15. Nebulizer systems: a new frontier for therapeutics and targeted delivery. Khairnar SV; Jain DD; Tambe SM; Chavan YR; Amin PD Ther Deliv; 2022 Jan; 13(1):31-49. PubMed ID: 34766509 [TBL] [Abstract][Full Text] [Related]
16. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Sakagami M Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473 [TBL] [Abstract][Full Text] [Related]
17. Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium. Conti DS; Brewer D; Grashik J; Avasarala S; da Rocha SR Mol Pharm; 2014 Jun; 11(6):1808-22. PubMed ID: 24811243 [TBL] [Abstract][Full Text] [Related]
18. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles. Xu Y; Harinck L; Lokras AG; Gerde P; Selg E; Sjöberg CO; Franzyk H; Thakur A; Foged C Int J Pharm; 2022 Jun; 621():121758. PubMed ID: 35483619 [TBL] [Abstract][Full Text] [Related]
19. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537 [TBL] [Abstract][Full Text] [Related]